A newly published study in Nature Communications has cast fresh light on the effects of cannabis—specifically tetrahydrocannabinol (THC)—on female fertility in patients undergoing in vitro fertilization (IVF). These findings come amid growing concerns over the increasingly normalized perception of cannabis as a benign, plant-based remedy.
Key Insights from Recent Research
The investigative team, led by clinical embryologist Cyntia Duval at Toronto’s CReATE Fertility Centre, explored how THC and its byproducts influence the maturation of oocytes—the vital precursor cells that develop into mature eggs. They analyzed follicular fluid collected during IVF procedures, discovering that higher THC concentrations correlated with a hastened but abnormal maturation process. Unfortunately, oocytes exposed to greater levels of THC were less likely to yield embryos with proper chromosomal division—compromised embryos seldom progress to implantation and, when they do, often result in miscarriage or stillbirth.
Further controlled laboratory testing on immature oocytes—typically discarded during IVF—replicated these findings. Both average and elevated THC exposures similarly disrupted chromosomal division. However, the study’s design precludes drawing broad conclusions about pregnancy outcomes: variables such as patient age may also affect results, particularly in one arm of the study where donor oocytes were used.
Context and Broader Implications
Although women can—and do—become pregnant after using cannabis, Duval emphasizes the significance of understanding its specific impacts on oocytes. Female fertility research remains limited, especially compared to the wealth of male-focused studies. Existing data shows that cannabis users—particularly males—often experience diminished sperm counts and increased rates of abnormal sperm morphology.
The study also underscores the challenges inherent in researching cannabis and reproduction: legal restrictions make recruitment difficult, and self-reporting on cannabis use is frequently unreliable. Indeed, in this IVF study, 73% of participants who tested positive for THC or its metabolites did not report cannabis use on intake questionnaires.
Why This Research Matters
THC interferes with the human endocannabinoid system—a complex signaling network that plays a crucial role in embryo transport and implantation. Introducing THC into this finely tuned system may disrupt natural reproductive processes by binding unpredictably to receptors involved in these functions.
Experts caution that while evidence linking alcohol or tobacco with reproductive harm is well-established, scientific understanding of cannabis remains nascent. Its legal status in many regions does not necessarily reflect safety, especially given the gaps in current research.
Final Thoughts
While more research is needed, particularly in real-world and long-term scenarios, these findings add fresh urgency to conversations about cannabis and fertility. For individuals pursuing pregnancy—whether naturally or through assisted methods—a prudent approach may be to avoid cannabis use altogether.
Dabbin-Dad Newsroom
